Introduction:
Acetylcholine (AChE) is an essential enzyme in neurotransmission, and its inhibition serves as a diagnostic marker for diseases like Alzheimer's and poisoning by organophosphates. We investigate an AChE-based electrochemical biosensor with an integrated microfluidic platform for the sensitive and rapid detection of AChE inhibitors. The biosensor utilizes a working electrode designed using MEMS (Micro-Electro-Mechanical Systems) technology, incorporating a Glassy Carbon Electrode (GCE), Gold Nanoparticles (AuNPs), PEDOT:PSS, and Carbon Nanotubes (CNTs), intended to detect pico-molar concentrations.
Methods:
The AChE enzyme was immobilized onto the electrode surface of a microfluidic chip, facilitating precise control of the sample, and the reagent flow was studied in an FEM-based numerical platform. The MEMS-based working electrode was designed, and subsequently, an optimized structure was fabricated. The said electrode featuring a GCE modified with AuNPs, PEDOT:PSS, and CNTs was designed to maximize the electron transfer and enhance the conductivity. This design enabled the sensor to detect AChE inhibitors with high sensitivity. Amperometric and cyclic voltametric techniques were employed to evaluate the sensor’s performance, including its detection limit, response time, and selectivity for common AChE inhibitors such as organophosphates. The mathematical modeling of the sensor included a mass transport equation for the electrode and the active molecules in the DLME, the electron transfer reaction on the working electrode, and the charge transfer kinetics. The model was validated and rigorously investigated through the depletion of concentrations of PBS and blood, where the applied potential affected the current through the electrolytes. The CV of the sensor was plotted for peak potential (0.4 v) and peak current (8 pA to 100 nA) measurements with respect to the concentration. Further, an EIS study was carried out, and the CV response was studied using different scan rates and redox couple concentrations. The observed peaks indicated the detection of biomolecules even at pico-molar concentrations.
Results:
The presented MEMS-based microfluidic integrated electrochemical biosensor demonstrated excellent pico-molar sensitivity, with detection limits as low as the 10 picomolar level for acetylcholine and its inhibitors. The inclusion of AuNPs and CNTs significantly enhanced the electrochemical response, while PEDOT:PSS improved the electrode's stability and conductivity. The microfluidic platform ensured rapid (< 10 seconds) and selective detection, with the sensor maintaining high sensitivity over several weeks of use.
Conclusions:
The presented AChE biosensor, designed using MEMS technology and an advanced electrode with multilayered materials, offers a highly sensitive, rapid, and cost-effective approach to detecting AChE inhibitors, even at pico-molar concentrations, in a robust device configuration. The integration of microfluidic control and MEMS technology enhances the system’s potential for applications in environmental monitoring, clinical diagnostics, and toxicological testing. Future improvements could focus on further optimizing the sensor for portability and enhancing its selectivity in complex biological matrices.